Skip to search.
 TSX Up 0.24% TSX Ventures Down 1.58%

Merck & Co. Inc. (MRK)

-NYSE
55.60 Up 0.68(1.24%) 4:01PM EDT
|After Hours : 55.61 Up 0.01 (0.02%) 5:30PM EDT - Nasdaq Real Time Price
Prev Close:54.92
Open:55.23
Bid:55.20 x 300
Ask:56.31 x 100
1y Target Est:61.55
Beta:0.741587
Next Earnings Date:29-Jul-16MRK Earnings announcement
Day's Range:55.18 - 55.88
52wk Range:45.69 - 61.70
Volume:6,311,193
Avg Vol (3m):8,900,000
Market Cap:153.90B
P/E (ttm):34.09
EPS (ttm):1.63
Div & Yield:1.84 (3.34%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
MRKUp 1.24%153.90B
GSKUp 1.67%103.74B
PFEUp 1.28%206.81B

Key Statistics

Forward P/E (1 yr):14.83
P/S (ttm):3.86
Ex-Dividend Date:11-Mar-16

Analysts

Annual EPS Est (Dec-16) :3.71
Quarterly EPS Est (Jun-16) :0.91
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):4.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infe... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback